Suchergebnisse - "Stone, Rebecca L"

PubPharm (133)

1

Pembrolizumab with bevacizumab and cyclophosphamide for the treatment of recurrent ovarian clear cell carcinoma : A case series

enthalten in: Gynecologic oncology reports | 2024

von Glynn, S. | Gaillard, S. | Stone, R. | +2

2

Long-term disease-free survival with chemotherapy and pembrolizumab in a patient with unmeasurable, advanced stage dedifferentiated endometrial carcinoma

enthalten in: Gynecologic oncology reports | 2024

von Davis, J. | Rushton, T. | Nsiah, F. | +5

3

Integrating Social Needs Screening and Resource Referral Into Standard Ambulatory Oncology Care : A Quality Improvement Project

enthalten in: JCO oncology practice | 2024

von Wethington, S. | Rositch, A. | Yu, R. | +6

4

Salpingectomy and Ovarian Cancer Prevention-Reply

enthalten in: JAMA surgery | 2024

von Kahn, R. | Stone, R. | Long Roche, K.

5

Robotic-assisted uterine transposition followed by anatomic pelvic repositioning for a patient with intramural fibroids and rectal cancer

enthalten in: Fertility and sterility | 2024

von Gornet, M. | Christianson, M. | Stone, R.

6

Salpingectomy for the Primary Prevention of Ovarian Cancer : A Systematic Review

enthalten in: JAMA surgery | 2023

von Kahn, R. | Gordhandas, S. | Godwin, K. | +4

ErratumIn: JAMA Surg. 2023 Oct 4;:. - PMID 37792367

7

Optimizing Perioperative Venous Thromboembolism Chemoprophylaxis on a Gynecologic Oncology Service

enthalten in: Journal of the American College of Surgeons | 2022

von Lippitt, M. | Johnson, E. | Frost, A. | +7

8

Successful Treatment of Paraneoplastic Neuropathy and Pruritis With Scrambler Therapy : A Case Report

enthalten in: Cureus | 2022

von Murphy, T. | Pardo, C. | Roda, R. | +2

9

Gynecologic oncology HPV vaccination practice patterns : Investigating practice barriers, knowledge gaps and opportunities for maximizing cervical cancer prevention

enthalten in: Gynecologic oncology reports | 2022

von Schneiter, M. | Levinson, K. | Rositch, A. | +5

10

Patients' and oncologists' preferences for second-line maintenance PARP inhibitor therapy in epithelial ovarian cancer

enthalten in: Future oncology (London, England) | 2022

von Stone, R. | Cambron-Mellott, M. | Beusterien, K. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]